Global Influenza A Vaccine Supply, Demand and Key Producers, 2023-2029
The global Influenza A Vaccine market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
This report studies the global Influenza A Vaccine production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Influenza A Vaccine, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Influenza A Vaccine that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Influenza A Vaccine total production and demand, 2018-2029, (K Units)
Global Influenza A Vaccine total production value, 2018-2029, (USD Million)
Global Influenza A Vaccine production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Influenza A Vaccine consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Influenza A Vaccine domestic production, consumption, key domestic manufacturers and share
Global Influenza A Vaccine production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Influenza A Vaccine production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Influenza A Vaccine production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Influenza A Vaccine market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novartis, Sanofi, GSK, Medimmune, Abbott, Mitsubishi Tanabe Pharma, Merck, Sinovac Biotech and Hualan Biological Engineering, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Influenza A Vaccine market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Influenza A Vaccine Market, By Region:
1. How big is the global Influenza A Vaccine market?
2. What is the demand of the global Influenza A Vaccine market?
3. What is the year over year growth of the global Influenza A Vaccine market?
4. What is the production and production value of the global Influenza A Vaccine market?
5. Who are the key producers in the global Influenza A Vaccine market?
6. What are the growth factors driving the market demand?
This report studies the global Influenza A Vaccine production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Influenza A Vaccine, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Influenza A Vaccine that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Influenza A Vaccine total production and demand, 2018-2029, (K Units)
Global Influenza A Vaccine total production value, 2018-2029, (USD Million)
Global Influenza A Vaccine production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Influenza A Vaccine consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Influenza A Vaccine domestic production, consumption, key domestic manufacturers and share
Global Influenza A Vaccine production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Influenza A Vaccine production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Influenza A Vaccine production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Influenza A Vaccine market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novartis, Sanofi, GSK, Medimmune, Abbott, Mitsubishi Tanabe Pharma, Merck, Sinovac Biotech and Hualan Biological Engineering, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Influenza A Vaccine market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Influenza A Vaccine Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Intramuscular Vaccine
- Nasal Spray Vaccine
- 3-18 Years Old
- Above 18 Years Old
- Novartis
- Sanofi
- GSK
- Medimmune
- Abbott
- Mitsubishi Tanabe Pharma
- Merck
- Sinovac Biotech
- Hualan Biological Engineering
- Changsheng Bio-Technology
- Beijing Tiantan Bio-Products
1. How big is the global Influenza A Vaccine market?
2. What is the demand of the global Influenza A Vaccine market?
3. What is the year over year growth of the global Influenza A Vaccine market?
4. What is the production and production value of the global Influenza A Vaccine market?
5. Who are the key producers in the global Influenza A Vaccine market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Influenza A Vaccine Introduction
1.2 World Influenza A Vaccine Supply & Forecast
1.2.1 World Influenza A Vaccine Production Value (2018 & 2022 & 2029)
1.2.2 World Influenza A Vaccine Production (2018-2029)
1.2.3 World Influenza A Vaccine Pricing Trends (2018-2029)
1.3 World Influenza A Vaccine Production by Region (Based on Production Site)
1.3.1 World Influenza A Vaccine Production Value by Region (2018-2029)
1.3.2 World Influenza A Vaccine Production by Region (2018-2029)
1.3.3 World Influenza A Vaccine Average Price by Region (2018-2029)
1.3.4 North America Influenza A Vaccine Production (2018-2029)
1.3.5 Europe Influenza A Vaccine Production (2018-2029)
1.3.6 China Influenza A Vaccine Production (2018-2029)
1.3.7 Japan Influenza A Vaccine Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Influenza A Vaccine Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Influenza A Vaccine Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Influenza A Vaccine Demand (2018-2029)
2.2 World Influenza A Vaccine Consumption by Region
2.2.1 World Influenza A Vaccine Consumption by Region (2018-2023)
2.2.2 World Influenza A Vaccine Consumption Forecast by Region (2024-2029)
2.3 United States Influenza A Vaccine Consumption (2018-2029)
2.4 China Influenza A Vaccine Consumption (2018-2029)
2.5 Europe Influenza A Vaccine Consumption (2018-2029)
2.6 Japan Influenza A Vaccine Consumption (2018-2029)
2.7 South Korea Influenza A Vaccine Consumption (2018-2029)
2.8 ASEAN Influenza A Vaccine Consumption (2018-2029)
2.9 India Influenza A Vaccine Consumption (2018-2029)
3 WORLD INFLUENZA A VACCINE MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Influenza A Vaccine Production Value by Manufacturer (2018-2023)
3.2 World Influenza A Vaccine Production by Manufacturer (2018-2023)
3.3 World Influenza A Vaccine Average Price by Manufacturer (2018-2023)
3.4 Influenza A Vaccine Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Influenza A Vaccine Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Influenza A Vaccine in 2022
3.5.3 Global Concentration Ratios (CR8) for Influenza A Vaccine in 2022
3.6 Influenza A Vaccine Market: Overall Company Footprint Analysis
3.6.1 Influenza A Vaccine Market: Region Footprint
3.6.2 Influenza A Vaccine Market: Company Product Type Footprint
3.6.3 Influenza A Vaccine Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Influenza A Vaccine Production Value Comparison
4.1.1 United States VS China: Influenza A Vaccine Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Influenza A Vaccine Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Influenza A Vaccine Production Comparison
4.2.1 United States VS China: Influenza A Vaccine Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Influenza A Vaccine Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Influenza A Vaccine Consumption Comparison
4.3.1 United States VS China: Influenza A Vaccine Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Influenza A Vaccine Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Influenza A Vaccine Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Influenza A Vaccine Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Influenza A Vaccine Production Value (2018-2023)
4.4.3 United States Based Manufacturers Influenza A Vaccine Production (2018-2023)
4.5 China Based Influenza A Vaccine Manufacturers and Market Share
4.5.1 China Based Influenza A Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Influenza A Vaccine Production Value (2018-2023)
4.5.3 China Based Manufacturers Influenza A Vaccine Production (2018-2023)
4.6 Rest of World Based Influenza A Vaccine Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Influenza A Vaccine Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Influenza A Vaccine Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Influenza A Vaccine Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Influenza A Vaccine Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Intramuscular Vaccine
5.2.2 Nasal Spray Vaccine
5.3 Market Segment by Type
5.3.1 World Influenza A Vaccine Production by Type (2018-2029)
5.3.2 World Influenza A Vaccine Production Value by Type (2018-2029)
5.3.3 World Influenza A Vaccine Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Influenza A Vaccine Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 3-18 Years Old
6.2.2 Above 18 Years Old
6.3 Market Segment by Application
6.3.1 World Influenza A Vaccine Production by Application (2018-2029)
6.3.2 World Influenza A Vaccine Production Value by Application (2018-2029)
6.3.3 World Influenza A Vaccine Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Novartis
7.1.1 Novartis Details
7.1.2 Novartis Major Business
7.1.3 Novartis Influenza A Vaccine Product and Services
7.1.4 Novartis Influenza A Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Novartis Recent Developments/Updates
7.1.6 Novartis Competitive Strengths & Weaknesses
7.2 Sanofi
7.2.1 Sanofi Details
7.2.2 Sanofi Major Business
7.2.3 Sanofi Influenza A Vaccine Product and Services
7.2.4 Sanofi Influenza A Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Sanofi Recent Developments/Updates
7.2.6 Sanofi Competitive Strengths & Weaknesses
7.3 GSK
7.3.1 GSK Details
7.3.2 GSK Major Business
7.3.3 GSK Influenza A Vaccine Product and Services
7.3.4 GSK Influenza A Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 GSK Recent Developments/Updates
7.3.6 GSK Competitive Strengths & Weaknesses
7.4 Medimmune
7.4.1 Medimmune Details
7.4.2 Medimmune Major Business
7.4.3 Medimmune Influenza A Vaccine Product and Services
7.4.4 Medimmune Influenza A Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Medimmune Recent Developments/Updates
7.4.6 Medimmune Competitive Strengths & Weaknesses
7.5 Abbott
7.5.1 Abbott Details
7.5.2 Abbott Major Business
7.5.3 Abbott Influenza A Vaccine Product and Services
7.5.4 Abbott Influenza A Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Abbott Recent Developments/Updates
7.5.6 Abbott Competitive Strengths & Weaknesses
7.6 Mitsubishi Tanabe Pharma
7.6.1 Mitsubishi Tanabe Pharma Details
7.6.2 Mitsubishi Tanabe Pharma Major Business
7.6.3 Mitsubishi Tanabe Pharma Influenza A Vaccine Product and Services
7.6.4 Mitsubishi Tanabe Pharma Influenza A Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Mitsubishi Tanabe Pharma Recent Developments/Updates
7.6.6 Mitsubishi Tanabe Pharma Competitive Strengths & Weaknesses
7.7 Merck
7.7.1 Merck Details
7.7.2 Merck Major Business
7.7.3 Merck Influenza A Vaccine Product and Services
7.7.4 Merck Influenza A Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Merck Recent Developments/Updates
7.7.6 Merck Competitive Strengths & Weaknesses
7.8 Sinovac Biotech
7.8.1 Sinovac Biotech Details
7.8.2 Sinovac Biotech Major Business
7.8.3 Sinovac Biotech Influenza A Vaccine Product and Services
7.8.4 Sinovac Biotech Influenza A Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Sinovac Biotech Recent Developments/Updates
7.8.6 Sinovac Biotech Competitive Strengths & Weaknesses
7.9 Hualan Biological Engineering
7.9.1 Hualan Biological Engineering Details
7.9.2 Hualan Biological Engineering Major Business
7.9.3 Hualan Biological Engineering Influenza A Vaccine Product and Services
7.9.4 Hualan Biological Engineering Influenza A Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Hualan Biological Engineering Recent Developments/Updates
7.9.6 Hualan Biological Engineering Competitive Strengths & Weaknesses
7.10 Changsheng Bio-Technology
7.10.1 Changsheng Bio-Technology Details
7.10.2 Changsheng Bio-Technology Major Business
7.10.3 Changsheng Bio-Technology Influenza A Vaccine Product and Services
7.10.4 Changsheng Bio-Technology Influenza A Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Changsheng Bio-Technology Recent Developments/Updates
7.10.6 Changsheng Bio-Technology Competitive Strengths & Weaknesses
7.11 Beijing Tiantan Bio-Products
7.11.1 Beijing Tiantan Bio-Products Details
7.11.2 Beijing Tiantan Bio-Products Major Business
7.11.3 Beijing Tiantan Bio-Products Influenza A Vaccine Product and Services
7.11.4 Beijing Tiantan Bio-Products Influenza A Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Beijing Tiantan Bio-Products Recent Developments/Updates
7.11.6 Beijing Tiantan Bio-Products Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Influenza A Vaccine Industry Chain
8.2 Influenza A Vaccine Upstream Analysis
8.2.1 Influenza A Vaccine Core Raw Materials
8.2.2 Main Manufacturers of Influenza A Vaccine Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Influenza A Vaccine Production Mode
8.6 Influenza A Vaccine Procurement Model
8.7 Influenza A Vaccine Industry Sales Model and Sales Channels
8.7.1 Influenza A Vaccine Sales Model
8.7.2 Influenza A Vaccine Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Influenza A Vaccine Introduction
1.2 World Influenza A Vaccine Supply & Forecast
1.2.1 World Influenza A Vaccine Production Value (2018 & 2022 & 2029)
1.2.2 World Influenza A Vaccine Production (2018-2029)
1.2.3 World Influenza A Vaccine Pricing Trends (2018-2029)
1.3 World Influenza A Vaccine Production by Region (Based on Production Site)
1.3.1 World Influenza A Vaccine Production Value by Region (2018-2029)
1.3.2 World Influenza A Vaccine Production by Region (2018-2029)
1.3.3 World Influenza A Vaccine Average Price by Region (2018-2029)
1.3.4 North America Influenza A Vaccine Production (2018-2029)
1.3.5 Europe Influenza A Vaccine Production (2018-2029)
1.3.6 China Influenza A Vaccine Production (2018-2029)
1.3.7 Japan Influenza A Vaccine Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Influenza A Vaccine Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Influenza A Vaccine Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Influenza A Vaccine Demand (2018-2029)
2.2 World Influenza A Vaccine Consumption by Region
2.2.1 World Influenza A Vaccine Consumption by Region (2018-2023)
2.2.2 World Influenza A Vaccine Consumption Forecast by Region (2024-2029)
2.3 United States Influenza A Vaccine Consumption (2018-2029)
2.4 China Influenza A Vaccine Consumption (2018-2029)
2.5 Europe Influenza A Vaccine Consumption (2018-2029)
2.6 Japan Influenza A Vaccine Consumption (2018-2029)
2.7 South Korea Influenza A Vaccine Consumption (2018-2029)
2.8 ASEAN Influenza A Vaccine Consumption (2018-2029)
2.9 India Influenza A Vaccine Consumption (2018-2029)
3 WORLD INFLUENZA A VACCINE MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Influenza A Vaccine Production Value by Manufacturer (2018-2023)
3.2 World Influenza A Vaccine Production by Manufacturer (2018-2023)
3.3 World Influenza A Vaccine Average Price by Manufacturer (2018-2023)
3.4 Influenza A Vaccine Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Influenza A Vaccine Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Influenza A Vaccine in 2022
3.5.3 Global Concentration Ratios (CR8) for Influenza A Vaccine in 2022
3.6 Influenza A Vaccine Market: Overall Company Footprint Analysis
3.6.1 Influenza A Vaccine Market: Region Footprint
3.6.2 Influenza A Vaccine Market: Company Product Type Footprint
3.6.3 Influenza A Vaccine Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Influenza A Vaccine Production Value Comparison
4.1.1 United States VS China: Influenza A Vaccine Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Influenza A Vaccine Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Influenza A Vaccine Production Comparison
4.2.1 United States VS China: Influenza A Vaccine Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Influenza A Vaccine Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Influenza A Vaccine Consumption Comparison
4.3.1 United States VS China: Influenza A Vaccine Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Influenza A Vaccine Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Influenza A Vaccine Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Influenza A Vaccine Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Influenza A Vaccine Production Value (2018-2023)
4.4.3 United States Based Manufacturers Influenza A Vaccine Production (2018-2023)
4.5 China Based Influenza A Vaccine Manufacturers and Market Share
4.5.1 China Based Influenza A Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Influenza A Vaccine Production Value (2018-2023)
4.5.3 China Based Manufacturers Influenza A Vaccine Production (2018-2023)
4.6 Rest of World Based Influenza A Vaccine Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Influenza A Vaccine Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Influenza A Vaccine Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Influenza A Vaccine Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Influenza A Vaccine Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Intramuscular Vaccine
5.2.2 Nasal Spray Vaccine
5.3 Market Segment by Type
5.3.1 World Influenza A Vaccine Production by Type (2018-2029)
5.3.2 World Influenza A Vaccine Production Value by Type (2018-2029)
5.3.3 World Influenza A Vaccine Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Influenza A Vaccine Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 3-18 Years Old
6.2.2 Above 18 Years Old
6.3 Market Segment by Application
6.3.1 World Influenza A Vaccine Production by Application (2018-2029)
6.3.2 World Influenza A Vaccine Production Value by Application (2018-2029)
6.3.3 World Influenza A Vaccine Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Novartis
7.1.1 Novartis Details
7.1.2 Novartis Major Business
7.1.3 Novartis Influenza A Vaccine Product and Services
7.1.4 Novartis Influenza A Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Novartis Recent Developments/Updates
7.1.6 Novartis Competitive Strengths & Weaknesses
7.2 Sanofi
7.2.1 Sanofi Details
7.2.2 Sanofi Major Business
7.2.3 Sanofi Influenza A Vaccine Product and Services
7.2.4 Sanofi Influenza A Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Sanofi Recent Developments/Updates
7.2.6 Sanofi Competitive Strengths & Weaknesses
7.3 GSK
7.3.1 GSK Details
7.3.2 GSK Major Business
7.3.3 GSK Influenza A Vaccine Product and Services
7.3.4 GSK Influenza A Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 GSK Recent Developments/Updates
7.3.6 GSK Competitive Strengths & Weaknesses
7.4 Medimmune
7.4.1 Medimmune Details
7.4.2 Medimmune Major Business
7.4.3 Medimmune Influenza A Vaccine Product and Services
7.4.4 Medimmune Influenza A Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Medimmune Recent Developments/Updates
7.4.6 Medimmune Competitive Strengths & Weaknesses
7.5 Abbott
7.5.1 Abbott Details
7.5.2 Abbott Major Business
7.5.3 Abbott Influenza A Vaccine Product and Services
7.5.4 Abbott Influenza A Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Abbott Recent Developments/Updates
7.5.6 Abbott Competitive Strengths & Weaknesses
7.6 Mitsubishi Tanabe Pharma
7.6.1 Mitsubishi Tanabe Pharma Details
7.6.2 Mitsubishi Tanabe Pharma Major Business
7.6.3 Mitsubishi Tanabe Pharma Influenza A Vaccine Product and Services
7.6.4 Mitsubishi Tanabe Pharma Influenza A Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Mitsubishi Tanabe Pharma Recent Developments/Updates
7.6.6 Mitsubishi Tanabe Pharma Competitive Strengths & Weaknesses
7.7 Merck
7.7.1 Merck Details
7.7.2 Merck Major Business
7.7.3 Merck Influenza A Vaccine Product and Services
7.7.4 Merck Influenza A Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Merck Recent Developments/Updates
7.7.6 Merck Competitive Strengths & Weaknesses
7.8 Sinovac Biotech
7.8.1 Sinovac Biotech Details
7.8.2 Sinovac Biotech Major Business
7.8.3 Sinovac Biotech Influenza A Vaccine Product and Services
7.8.4 Sinovac Biotech Influenza A Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Sinovac Biotech Recent Developments/Updates
7.8.6 Sinovac Biotech Competitive Strengths & Weaknesses
7.9 Hualan Biological Engineering
7.9.1 Hualan Biological Engineering Details
7.9.2 Hualan Biological Engineering Major Business
7.9.3 Hualan Biological Engineering Influenza A Vaccine Product and Services
7.9.4 Hualan Biological Engineering Influenza A Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Hualan Biological Engineering Recent Developments/Updates
7.9.6 Hualan Biological Engineering Competitive Strengths & Weaknesses
7.10 Changsheng Bio-Technology
7.10.1 Changsheng Bio-Technology Details
7.10.2 Changsheng Bio-Technology Major Business
7.10.3 Changsheng Bio-Technology Influenza A Vaccine Product and Services
7.10.4 Changsheng Bio-Technology Influenza A Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Changsheng Bio-Technology Recent Developments/Updates
7.10.6 Changsheng Bio-Technology Competitive Strengths & Weaknesses
7.11 Beijing Tiantan Bio-Products
7.11.1 Beijing Tiantan Bio-Products Details
7.11.2 Beijing Tiantan Bio-Products Major Business
7.11.3 Beijing Tiantan Bio-Products Influenza A Vaccine Product and Services
7.11.4 Beijing Tiantan Bio-Products Influenza A Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Beijing Tiantan Bio-Products Recent Developments/Updates
7.11.6 Beijing Tiantan Bio-Products Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Influenza A Vaccine Industry Chain
8.2 Influenza A Vaccine Upstream Analysis
8.2.1 Influenza A Vaccine Core Raw Materials
8.2.2 Main Manufacturers of Influenza A Vaccine Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Influenza A Vaccine Production Mode
8.6 Influenza A Vaccine Procurement Model
8.7 Influenza A Vaccine Industry Sales Model and Sales Channels
8.7.1 Influenza A Vaccine Sales Model
8.7.2 Influenza A Vaccine Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Influenza A Vaccine Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Influenza A Vaccine Production Value by Region (2018-2023) & (USD Million)
Table 3. World Influenza A Vaccine Production Value by Region (2024-2029) & (USD Million)
Table 4. World Influenza A Vaccine Production Value Market Share by Region (2018-2023)
Table 5. World Influenza A Vaccine Production Value Market Share by Region (2024-2029)
Table 6. World Influenza A Vaccine Production by Region (2018-2023) & (K Units)
Table 7. World Influenza A Vaccine Production by Region (2024-2029) & (K Units)
Table 8. World Influenza A Vaccine Production Market Share by Region (2018-2023)
Table 9. World Influenza A Vaccine Production Market Share by Region (2024-2029)
Table 10. World Influenza A Vaccine Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Influenza A Vaccine Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Influenza A Vaccine Major Market Trends
Table 13. World Influenza A Vaccine Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Influenza A Vaccine Consumption by Region (2018-2023) & (K Units)
Table 15. World Influenza A Vaccine Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Influenza A Vaccine Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Influenza A Vaccine Producers in 2022
Table 18. World Influenza A Vaccine Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Influenza A Vaccine Producers in 2022
Table 20. World Influenza A Vaccine Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Influenza A Vaccine Company Evaluation Quadrant
Table 22. World Influenza A Vaccine Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Influenza A Vaccine Production Site of Key Manufacturer
Table 24. Influenza A Vaccine Market: Company Product Type Footprint
Table 25. Influenza A Vaccine Market: Company Product Application Footprint
Table 26. Influenza A Vaccine Competitive Factors
Table 27. Influenza A Vaccine New Entrant and Capacity Expansion Plans
Table 28. Influenza A Vaccine Mergers & Acquisitions Activity
Table 29. United States VS China Influenza A Vaccine Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Influenza A Vaccine Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Influenza A Vaccine Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Influenza A Vaccine Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Influenza A Vaccine Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Influenza A Vaccine Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Influenza A Vaccine Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Influenza A Vaccine Production Market Share (2018-2023)
Table 37. China Based Influenza A Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Influenza A Vaccine Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Influenza A Vaccine Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Influenza A Vaccine Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Influenza A Vaccine Production Market Share (2018-2023)
Table 42. Rest of World Based Influenza A Vaccine Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Influenza A Vaccine Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Influenza A Vaccine Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Influenza A Vaccine Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Influenza A Vaccine Production Market Share (2018-2023)
Table 47. World Influenza A Vaccine Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Influenza A Vaccine Production by Type (2018-2023) & (K Units)
Table 49. World Influenza A Vaccine Production by Type (2024-2029) & (K Units)
Table 50. World Influenza A Vaccine Production Value by Type (2018-2023) & (USD Million)
Table 51. World Influenza A Vaccine Production Value by Type (2024-2029) & (USD Million)
Table 52. World Influenza A Vaccine Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Influenza A Vaccine Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Influenza A Vaccine Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Influenza A Vaccine Production by Application (2018-2023) & (K Units)
Table 56. World Influenza A Vaccine Production by Application (2024-2029) & (K Units)
Table 57. World Influenza A Vaccine Production Value by Application (2018-2023) & (USD Million)
Table 58. World Influenza A Vaccine Production Value by Application (2024-2029) & (USD Million)
Table 59. World Influenza A Vaccine Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Influenza A Vaccine Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Novartis Basic Information, Manufacturing Base and Competitors
Table 62. Novartis Major Business
Table 63. Novartis Influenza A Vaccine Product and Services
Table 64. Novartis Influenza A Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Novartis Recent Developments/Updates
Table 66. Novartis Competitive Strengths & Weaknesses
Table 67. Sanofi Basic Information, Manufacturing Base and Competitors
Table 68. Sanofi Major Business
Table 69. Sanofi Influenza A Vaccine Product and Services
Table 70. Sanofi Influenza A Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Sanofi Recent Developments/Updates
Table 72. Sanofi Competitive Strengths & Weaknesses
Table 73. GSK Basic Information, Manufacturing Base and Competitors
Table 74. GSK Major Business
Table 75. GSK Influenza A Vaccine Product and Services
Table 76. GSK Influenza A Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. GSK Recent Developments/Updates
Table 78. GSK Competitive Strengths & Weaknesses
Table 79. Medimmune Basic Information, Manufacturing Base and Competitors
Table 80. Medimmune Major Business
Table 81. Medimmune Influenza A Vaccine Product and Services
Table 82. Medimmune Influenza A Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Medimmune Recent Developments/Updates
Table 84. Medimmune Competitive Strengths & Weaknesses
Table 85. Abbott Basic Information, Manufacturing Base and Competitors
Table 86. Abbott Major Business
Table 87. Abbott Influenza A Vaccine Product and Services
Table 88. Abbott Influenza A Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Abbott Recent Developments/Updates
Table 90. Abbott Competitive Strengths & Weaknesses
Table 91. Mitsubishi Tanabe Pharma Basic Information, Manufacturing Base and Competitors
Table 92. Mitsubishi Tanabe Pharma Major Business
Table 93. Mitsubishi Tanabe Pharma Influenza A Vaccine Product and Services
Table 94. Mitsubishi Tanabe Pharma Influenza A Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Mitsubishi Tanabe Pharma Recent Developments/Updates
Table 96. Mitsubishi Tanabe Pharma Competitive Strengths & Weaknesses
Table 97. Merck Basic Information, Manufacturing Base and Competitors
Table 98. Merck Major Business
Table 99. Merck Influenza A Vaccine Product and Services
Table 100. Merck Influenza A Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Merck Recent Developments/Updates
Table 102. Merck Competitive Strengths & Weaknesses
Table 103. Sinovac Biotech Basic Information, Manufacturing Base and Competitors
Table 104. Sinovac Biotech Major Business
Table 105. Sinovac Biotech Influenza A Vaccine Product and Services
Table 106. Sinovac Biotech Influenza A Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Sinovac Biotech Recent Developments/Updates
Table 108. Sinovac Biotech Competitive Strengths & Weaknesses
Table 109. Hualan Biological Engineering Basic Information, Manufacturing Base and Competitors
Table 110. Hualan Biological Engineering Major Business
Table 111. Hualan Biological Engineering Influenza A Vaccine Product and Services
Table 112. Hualan Biological Engineering Influenza A Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Hualan Biological Engineering Recent Developments/Updates
Table 114. Hualan Biological Engineering Competitive Strengths & Weaknesses
Table 115. Changsheng Bio-Technology Basic Information, Manufacturing Base and Competitors
Table 116. Changsheng Bio-Technology Major Business
Table 117. Changsheng Bio-Technology Influenza A Vaccine Product and Services
Table 118. Changsheng Bio-Technology Influenza A Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Changsheng Bio-Technology Recent Developments/Updates
Table 120. Beijing Tiantan Bio-Products Basic Information, Manufacturing Base and Competitors
Table 121. Beijing Tiantan Bio-Products Major Business
Table 122. Beijing Tiantan Bio-Products Influenza A Vaccine Product and Services
Table 123. Beijing Tiantan Bio-Products Influenza A Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 124. Global Key Players of Influenza A Vaccine Upstream (Raw Materials)
Table 125. Influenza A Vaccine Typical Customers
Table 126. Influenza A Vaccine Typical Distributors
Table 1. World Influenza A Vaccine Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Influenza A Vaccine Production Value by Region (2018-2023) & (USD Million)
Table 3. World Influenza A Vaccine Production Value by Region (2024-2029) & (USD Million)
Table 4. World Influenza A Vaccine Production Value Market Share by Region (2018-2023)
Table 5. World Influenza A Vaccine Production Value Market Share by Region (2024-2029)
Table 6. World Influenza A Vaccine Production by Region (2018-2023) & (K Units)
Table 7. World Influenza A Vaccine Production by Region (2024-2029) & (K Units)
Table 8. World Influenza A Vaccine Production Market Share by Region (2018-2023)
Table 9. World Influenza A Vaccine Production Market Share by Region (2024-2029)
Table 10. World Influenza A Vaccine Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Influenza A Vaccine Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Influenza A Vaccine Major Market Trends
Table 13. World Influenza A Vaccine Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Influenza A Vaccine Consumption by Region (2018-2023) & (K Units)
Table 15. World Influenza A Vaccine Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Influenza A Vaccine Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Influenza A Vaccine Producers in 2022
Table 18. World Influenza A Vaccine Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Influenza A Vaccine Producers in 2022
Table 20. World Influenza A Vaccine Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Influenza A Vaccine Company Evaluation Quadrant
Table 22. World Influenza A Vaccine Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Influenza A Vaccine Production Site of Key Manufacturer
Table 24. Influenza A Vaccine Market: Company Product Type Footprint
Table 25. Influenza A Vaccine Market: Company Product Application Footprint
Table 26. Influenza A Vaccine Competitive Factors
Table 27. Influenza A Vaccine New Entrant and Capacity Expansion Plans
Table 28. Influenza A Vaccine Mergers & Acquisitions Activity
Table 29. United States VS China Influenza A Vaccine Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Influenza A Vaccine Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Influenza A Vaccine Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Influenza A Vaccine Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Influenza A Vaccine Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Influenza A Vaccine Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Influenza A Vaccine Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Influenza A Vaccine Production Market Share (2018-2023)
Table 37. China Based Influenza A Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Influenza A Vaccine Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Influenza A Vaccine Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Influenza A Vaccine Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Influenza A Vaccine Production Market Share (2018-2023)
Table 42. Rest of World Based Influenza A Vaccine Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Influenza A Vaccine Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Influenza A Vaccine Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Influenza A Vaccine Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Influenza A Vaccine Production Market Share (2018-2023)
Table 47. World Influenza A Vaccine Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Influenza A Vaccine Production by Type (2018-2023) & (K Units)
Table 49. World Influenza A Vaccine Production by Type (2024-2029) & (K Units)
Table 50. World Influenza A Vaccine Production Value by Type (2018-2023) & (USD Million)
Table 51. World Influenza A Vaccine Production Value by Type (2024-2029) & (USD Million)
Table 52. World Influenza A Vaccine Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Influenza A Vaccine Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Influenza A Vaccine Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Influenza A Vaccine Production by Application (2018-2023) & (K Units)
Table 56. World Influenza A Vaccine Production by Application (2024-2029) & (K Units)
Table 57. World Influenza A Vaccine Production Value by Application (2018-2023) & (USD Million)
Table 58. World Influenza A Vaccine Production Value by Application (2024-2029) & (USD Million)
Table 59. World Influenza A Vaccine Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Influenza A Vaccine Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Novartis Basic Information, Manufacturing Base and Competitors
Table 62. Novartis Major Business
Table 63. Novartis Influenza A Vaccine Product and Services
Table 64. Novartis Influenza A Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Novartis Recent Developments/Updates
Table 66. Novartis Competitive Strengths & Weaknesses
Table 67. Sanofi Basic Information, Manufacturing Base and Competitors
Table 68. Sanofi Major Business
Table 69. Sanofi Influenza A Vaccine Product and Services
Table 70. Sanofi Influenza A Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Sanofi Recent Developments/Updates
Table 72. Sanofi Competitive Strengths & Weaknesses
Table 73. GSK Basic Information, Manufacturing Base and Competitors
Table 74. GSK Major Business
Table 75. GSK Influenza A Vaccine Product and Services
Table 76. GSK Influenza A Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. GSK Recent Developments/Updates
Table 78. GSK Competitive Strengths & Weaknesses
Table 79. Medimmune Basic Information, Manufacturing Base and Competitors
Table 80. Medimmune Major Business
Table 81. Medimmune Influenza A Vaccine Product and Services
Table 82. Medimmune Influenza A Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Medimmune Recent Developments/Updates
Table 84. Medimmune Competitive Strengths & Weaknesses
Table 85. Abbott Basic Information, Manufacturing Base and Competitors
Table 86. Abbott Major Business
Table 87. Abbott Influenza A Vaccine Product and Services
Table 88. Abbott Influenza A Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Abbott Recent Developments/Updates
Table 90. Abbott Competitive Strengths & Weaknesses
Table 91. Mitsubishi Tanabe Pharma Basic Information, Manufacturing Base and Competitors
Table 92. Mitsubishi Tanabe Pharma Major Business
Table 93. Mitsubishi Tanabe Pharma Influenza A Vaccine Product and Services
Table 94. Mitsubishi Tanabe Pharma Influenza A Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Mitsubishi Tanabe Pharma Recent Developments/Updates
Table 96. Mitsubishi Tanabe Pharma Competitive Strengths & Weaknesses
Table 97. Merck Basic Information, Manufacturing Base and Competitors
Table 98. Merck Major Business
Table 99. Merck Influenza A Vaccine Product and Services
Table 100. Merck Influenza A Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Merck Recent Developments/Updates
Table 102. Merck Competitive Strengths & Weaknesses
Table 103. Sinovac Biotech Basic Information, Manufacturing Base and Competitors
Table 104. Sinovac Biotech Major Business
Table 105. Sinovac Biotech Influenza A Vaccine Product and Services
Table 106. Sinovac Biotech Influenza A Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Sinovac Biotech Recent Developments/Updates
Table 108. Sinovac Biotech Competitive Strengths & Weaknesses
Table 109. Hualan Biological Engineering Basic Information, Manufacturing Base and Competitors
Table 110. Hualan Biological Engineering Major Business
Table 111. Hualan Biological Engineering Influenza A Vaccine Product and Services
Table 112. Hualan Biological Engineering Influenza A Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Hualan Biological Engineering Recent Developments/Updates
Table 114. Hualan Biological Engineering Competitive Strengths & Weaknesses
Table 115. Changsheng Bio-Technology Basic Information, Manufacturing Base and Competitors
Table 116. Changsheng Bio-Technology Major Business
Table 117. Changsheng Bio-Technology Influenza A Vaccine Product and Services
Table 118. Changsheng Bio-Technology Influenza A Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Changsheng Bio-Technology Recent Developments/Updates
Table 120. Beijing Tiantan Bio-Products Basic Information, Manufacturing Base and Competitors
Table 121. Beijing Tiantan Bio-Products Major Business
Table 122. Beijing Tiantan Bio-Products Influenza A Vaccine Product and Services
Table 123. Beijing Tiantan Bio-Products Influenza A Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 124. Global Key Players of Influenza A Vaccine Upstream (Raw Materials)
Table 125. Influenza A Vaccine Typical Customers
Table 126. Influenza A Vaccine Typical Distributors
LIST OF FIGURES
Figure 1. Influenza A Vaccine Picture
Figure 2. World Influenza A Vaccine Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Influenza A Vaccine Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Influenza A Vaccine Production (2018-2029) & (K Units)
Figure 5. World Influenza A Vaccine Average Price (2018-2029) & (US$/Unit)
Figure 6. World Influenza A Vaccine Production Value Market Share by Region (2018-2029)
Figure 7. World Influenza A Vaccine Production Market Share by Region (2018-2029)
Figure 8. North America Influenza A Vaccine Production (2018-2029) & (K Units)
Figure 9. Europe Influenza A Vaccine Production (2018-2029) & (K Units)
Figure 10. China Influenza A Vaccine Production (2018-2029) & (K Units)
Figure 11. Japan Influenza A Vaccine Production (2018-2029) & (K Units)
Figure 12. Influenza A Vaccine Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Influenza A Vaccine Consumption (2018-2029) & (K Units)
Figure 15. World Influenza A Vaccine Consumption Market Share by Region (2018-2029)
Figure 16. United States Influenza A Vaccine Consumption (2018-2029) & (K Units)
Figure 17. China Influenza A Vaccine Consumption (2018-2029) & (K Units)
Figure 18. Europe Influenza A Vaccine Consumption (2018-2029) & (K Units)
Figure 19. Japan Influenza A Vaccine Consumption (2018-2029) & (K Units)
Figure 20. South Korea Influenza A Vaccine Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Influenza A Vaccine Consumption (2018-2029) & (K Units)
Figure 22. India Influenza A Vaccine Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Influenza A Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Influenza A Vaccine Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Influenza A Vaccine Markets in 2022
Figure 26. United States VS China: Influenza A Vaccine Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Influenza A Vaccine Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Influenza A Vaccine Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Influenza A Vaccine Production Market Share 2022
Figure 30. China Based Manufacturers Influenza A Vaccine Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Influenza A Vaccine Production Market Share 2022
Figure 32. World Influenza A Vaccine Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Influenza A Vaccine Production Value Market Share by Type in 2022
Figure 34. Intramuscular Vaccine
Figure 35. Nasal Spray Vaccine
Figure 36. World Influenza A Vaccine Production Market Share by Type (2018-2029)
Figure 37. World Influenza A Vaccine Production Value Market Share by Type (2018-2029)
Figure 38. World Influenza A Vaccine Average Price by Type (2018-2029) & (US$/Unit)
Figure 39. World Influenza A Vaccine Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World Influenza A Vaccine Production Value Market Share by Application in 2022
Figure 41. 3-18 Years Old
Figure 42. Above 18 Years Old
Figure 43. World Influenza A Vaccine Production Market Share by Application (2018-2029)
Figure 44. World Influenza A Vaccine Production Value Market Share by Application (2018-2029)
Figure 45. World Influenza A Vaccine Average Price by Application (2018-2029) & (US$/Unit)
Figure 46. Influenza A Vaccine Industry Chain
Figure 47. Influenza A Vaccine Procurement Model
Figure 48. Influenza A Vaccine Sales Model
Figure 49. Influenza A Vaccine Sales Channels, Direct Sales, and Distribution
Figure 50. Methodology
Figure 51. Research Process and Data Source
Figure 1. Influenza A Vaccine Picture
Figure 2. World Influenza A Vaccine Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Influenza A Vaccine Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Influenza A Vaccine Production (2018-2029) & (K Units)
Figure 5. World Influenza A Vaccine Average Price (2018-2029) & (US$/Unit)
Figure 6. World Influenza A Vaccine Production Value Market Share by Region (2018-2029)
Figure 7. World Influenza A Vaccine Production Market Share by Region (2018-2029)
Figure 8. North America Influenza A Vaccine Production (2018-2029) & (K Units)
Figure 9. Europe Influenza A Vaccine Production (2018-2029) & (K Units)
Figure 10. China Influenza A Vaccine Production (2018-2029) & (K Units)
Figure 11. Japan Influenza A Vaccine Production (2018-2029) & (K Units)
Figure 12. Influenza A Vaccine Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Influenza A Vaccine Consumption (2018-2029) & (K Units)
Figure 15. World Influenza A Vaccine Consumption Market Share by Region (2018-2029)
Figure 16. United States Influenza A Vaccine Consumption (2018-2029) & (K Units)
Figure 17. China Influenza A Vaccine Consumption (2018-2029) & (K Units)
Figure 18. Europe Influenza A Vaccine Consumption (2018-2029) & (K Units)
Figure 19. Japan Influenza A Vaccine Consumption (2018-2029) & (K Units)
Figure 20. South Korea Influenza A Vaccine Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Influenza A Vaccine Consumption (2018-2029) & (K Units)
Figure 22. India Influenza A Vaccine Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Influenza A Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Influenza A Vaccine Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Influenza A Vaccine Markets in 2022
Figure 26. United States VS China: Influenza A Vaccine Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Influenza A Vaccine Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Influenza A Vaccine Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Influenza A Vaccine Production Market Share 2022
Figure 30. China Based Manufacturers Influenza A Vaccine Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Influenza A Vaccine Production Market Share 2022
Figure 32. World Influenza A Vaccine Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Influenza A Vaccine Production Value Market Share by Type in 2022
Figure 34. Intramuscular Vaccine
Figure 35. Nasal Spray Vaccine
Figure 36. World Influenza A Vaccine Production Market Share by Type (2018-2029)
Figure 37. World Influenza A Vaccine Production Value Market Share by Type (2018-2029)
Figure 38. World Influenza A Vaccine Average Price by Type (2018-2029) & (US$/Unit)
Figure 39. World Influenza A Vaccine Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World Influenza A Vaccine Production Value Market Share by Application in 2022
Figure 41. 3-18 Years Old
Figure 42. Above 18 Years Old
Figure 43. World Influenza A Vaccine Production Market Share by Application (2018-2029)
Figure 44. World Influenza A Vaccine Production Value Market Share by Application (2018-2029)
Figure 45. World Influenza A Vaccine Average Price by Application (2018-2029) & (US$/Unit)
Figure 46. Influenza A Vaccine Industry Chain
Figure 47. Influenza A Vaccine Procurement Model
Figure 48. Influenza A Vaccine Sales Model
Figure 49. Influenza A Vaccine Sales Channels, Direct Sales, and Distribution
Figure 50. Methodology
Figure 51. Research Process and Data Source
